Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOTUM | Q6P988 | 14/20 | 0.49 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.44 |
| ▸ | HCRTR1 | O43613 | 2/20 | 0.41 |
| ▸ | HCRTR2 | O43614 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1696198 | 0.86 | NOTUM (0.47) | NOTUMKEAP1HCRTR1HCRTR2 | |
| SCHEMBL17422567 | 0.86 | NOTUM (0.51) | NOTUMKEAP1HCRTR1HCRTR2 | |
| SCHEMBL28457554 | 0.84 | MYC (0.50) | NOTUMHCRTR1HCRTR2 | |
| SCHEMBL19894027 | 0.83 | MYC (0.51) | NOTUM | |
| SCHEMBL18016687 | 0.83 | NOTUM (0.51) | NOTUMKEAP1 | |
| SCHEMBL17984483 | 0.83 | NOTUM (0.51) | NOTUMKEAP1HCRTR1HCRTR2 | |
| SCHEMBL5790843 | 0.83 | NOTUM (0.47) | NOTUMHCRTR1HCRTR2 | |
| SCHEMBL30767902 | 0.82 | NOTUM (0.46) | NOTUM | |
| SCHEMBL15882104 | 0.80 | NOTUM (0.51) | NOTUMKEAP1HCRTR1HCRTR2 | |
| SCHEMBL1586107 | 0.80 | HCRTR1 (0.58) | NOTUMHCRTR1HCRTR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009054785-A1 | 1,2,4-TRIAZOLE ETHER DERIVATIVES AS MODULATORS OF MGLUR5 | ASTRAZENECA AB (SE) | 2009-04-30 | — | — | WO | claimed |
| EP-1978997-A1 | TRANSDERMAL DELIVERY OF PHARMACEUTICAL AGENTS | Apollo Life Sciences Limited (AU) | 2008-10-15 | — | — | EP | claimed |
| WO-2007070983-A1 | TRANSDERMAL DELIVERY OF PHARMACEUTICAL AGENTS | APOLLO LIFE SCIENCES LIMITED (AU) | 2007-06-28 | — | — | WO | claimed |
| EP-3538088-A1 | HETEROCYCLIC MODULATORS OF LIPID SYNTHESIS | 3-V Biosciences, Inc. (US) | 2019-09-18 | — | — | EP | disclosed |
| WO-2019016637-A1 | A PROCESS FOR THE PREPARATION OF DEFERASIROX | AUROBINDO PHARMA LIMITED (IN) | 2019-01-24 | — | — | WO | disclosed |
| WO-2018089904-A1 | HETEROCYCLIC MODULATORS OF LIPID SYNTHESIS | 3-V BIOSCIENCES, INC. (US) | 2018-05-17 | — | — | WO | disclosed |
| EP-3166404-A1 | IMPROVED PROCESS FOR PREPARATION OF 4-(1-(4-(PERFLUOROETHOXY)PHENYL)-1H-1,2,4-TRIAZOL-3-YL)BENZOYL AZIDE | Dow AgroSciences LLC (US) | 2017-05-17 | — | — | EP | disclosed |
| WO-2016007726-A1 | IMPROVED PROCESS FOR PREPARATION OF 4-(1-(4-(PERFLUOROETHOXY)PHENYL)-1H-1,2,4-TRIAZOL-3-YL)BENZOYL AZIDE | DOW AGROSCIENCES LLC (US) | 2016-01-14 | — | — | WO | disclosed |
| EP-2925322-A1 | INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL | Merck Sharp & Dohme Corp. (US) | 2015-10-07 | — | — | EP | disclosed |
| WO-2014085210-A1 | INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL | MERCK SHARP & DOHME CORP. (US) | 2014-06-05 | — | — | WO | disclosed |
| EP-2718284-A1 | TRIAZOLONE COMPOUNDS AS mPGES-1 INHIBITORS | Glenmark Pharmaceuticals S.A. (CH) | 2014-04-16 | — | — | EP | disclosed |
| WO-2013186692-A1 | TRIAZOLONE COMPOUNDS AS mPGES-1 INHIBITORS | GLENMARK PHARMACEUTICALS S.A. (CH) | 2013-12-19 | — | — | WO | disclosed |
| EP-2137170-A1 | DESFERRITHIOCIN POLYETHER ANALOGUES | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2009-12-30 | — | — | EP | disclosed |
| EP-2046762-A2 | TRIAZOLYL PHENYL BENZENESULFONAMIDES | ChemoCentryx Inc (US) | 2009-04-15 | — | — | EP | disclosed |
| WO-2008115433-A1 | DESFERRITHIOCIN POLYETHER ANALOGUES | UNIVERSITY OF FLORIDA (US) | 2008-09-25 | — | — | WO | disclosed |
| WO-2008010934-A2 | TRIAZOLYL PHENYL BENZENESULFONAMIDES | CHEMOCENTRYX, INC. (US) | 2008-01-24 | — | — | WO | disclosed |